Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding status and NIH operating updates; the NiTraSarc study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T19:58:28.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The update appears to be cosmetic updates to the page layout and formatting. There are no changes to the study's purpose, eligibility criteria, primary/secondary outcomes, or scheduling details.
    Difference
    0.4%
    Check dated 2025-11-03T13:45:52.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:24:07.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:40:26.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a minor patch to the core content. The 'Back to Top' link was removed as a minor UI adjustment.
    Difference
    0.2%
    Check dated 2025-09-14T09:56:44.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T07:59:31.000Z thumbnail image

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.